Trials / Conditions / Non-small Cell Lung Cancer Stage I

Non-small Cell Lung Cancer Stage I

22 registered clinical trials studyying Non-small Cell Lung Cancer Stage I — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial L NCT07323732	Memorial Sloan Kettering Cancer Center	Phase 2
Unknown	Combining ICI With SBRT or HypoFrx-RT for ES NSCLC NCT05451173	Alexander Chi	Phase 1 / Phase 2
Withdrawn	SCION: SABR and Checkpoint Inhibition of NSCLC NCT04944173	University of British Columbia	Phase 2
Unknown	Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer NCT06341387	European Institute of Oncology	—
Recruiting	Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Defla NCT05453721	The First Affiliated Hospital of Nanchang University	N/A
Unknown	Traditional Chinese Medicine Combined With Thermal and Cold Ablation for Early-stage Lung Cancer NCT05097417	Shanghai 10th People's Hospital	N/A
Recruiting	Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E) NCT04585477	Stanford University	Phase 2
Active Not Recruiting	Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy NCT04716946	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	The Canada Lymph Node Score Project: A Crossover Trial NCT04342377	St. Joseph's Healthcare Hamilton	Phase 3
Completed	Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer NCT04271384	Hospital Israelita Albert Einstein	Phase 2
Completed	Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003) NCT03216551	Fudan University	—
Completed	Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer NCT03603002	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	N/A
Completed	SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects NCT03383302	Royal Marsden NHS Foundation Trust	Phase 1 / Phase 2
Withdrawn	Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung Cancer NCT03431415	Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec	N/A
Completed	ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS NCT03172156	Sun Yat-sen University	—
Withdrawn	Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer NCT03029871	Benjamin Movsas, M.D.	Phase 1
Unknown	Segmentectomy vs Lobectomy NCT06180239	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Recruiting	Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Pa NCT02622581	AIO-Studien-gGmbH	—
Unknown	LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC NCT01795521	European Organisation for Research and Treatment of Cancer - EORTC	Phase 2
Completed	Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC NCT07250360	The First Affiliated Hospital with Nanjing Medical University	—
Unknown	Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion NCT02011997	The First Affiliated Hospital of Guangzhou Medical University	Phase 3
Completed	Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC) NCT01991418	Hunan Province Tumor Hospital	—